Literature DB >> 8981955

Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23.

B E Baysal1, J E Farr, W S Rubinstein, R A Galus, K A Johnson, C E Aston, E N Myers, J T Johnson, R Carrau, S J Kirkpatrick, D Myssiorek, D Singh, S Saha, S M Gollin, G A Evans, M R James, C W Richard.   

Abstract

Hereditary nonchromaffin paragangliomas (PGL; glomus tumors; MIM 168000) are mostly benign, slow-growing tumors of the head and neck region, inherited from carrier fathers in an autosomal dominant fashion subject to genomic imprinting. Genetic linkage analysis in two large, unrelated Dutch families assigned PGL loci to two regions of chromosome 11, at 11q23 (PGL1) and 11q13.1 (PGL2). We ascertained a total of 11 North American PGL families and confirmed maternal imprinting (inactivation). In three of six families, linkage analysis provided evidence of linkage to the PGL1 locus at 11q23. Recombinants narrowed the critical region to an approximately 4.5-Mb interval flanked by markers D11S1647 and D11S622. Partial allelic loss of strictly maternal origin was detected in 5 of 19 tumors. The greatest degree of imbalance was detected at 11q23, distal to D11S1327 and proximal to CD3D. Age at onset of symptoms was significantly different between fathers and children (Wilcoxon rank-sum test, P < .002). Affected children had an earlier age at onset of symptoms in 39 of 57 father-child pairs (chi2 = 7.74, P < .006). However, a more conservative comparison of the number of pairs in which a child had > or = 5 years earlier age at onset (n = 33) vis-a-vis that of complementary pairs (n = 24) revealed no significant difference (chi2 = 1.42, P > .2). Whether these data represent genetic anticipation or ascertainment bias can be addressed only by analysis of a larger number of father-child pairs.

Entities:  

Mesh:

Year:  1997        PMID: 8981955      PMCID: PMC1712548     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers.

Authors:  I P Tomlinson; A J Gammack; J E Stickland; G J Mann; R M MacKie; R F Kefford; J O McGee
Journal:  Genes Chromosomes Cancer       Date:  1993-07       Impact factor: 5.006

2.  Deletion of chromosome 11 and of 14q sequences in neuroblastoma.

Authors:  E S Srivatsan; K L Ying; R C Seeger
Journal:  Genes Chromosomes Cancer       Date:  1993-05       Impact factor: 5.006

3.  Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11.

Authors:  M Koi; L A Johnson; L M Kalikin; P F Little; Y Nakamura; A P Feinberg
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

4.  Anticipation in myotonic dystrophy. I. Statistical verification based on clinical and haplotype findings.

Authors:  T Ashizawa; C J Dunne; J R Dubel; M B Perryman; H F Epstein; E Boerwinkle; J F Hejtmancik
Journal:  Neurology       Date:  1992-10       Impact factor: 9.910

5.  Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24.

Authors:  G M Hampton; L A Penny; R N Baergen; A Larson; C Brewer; S Liao; R M Busby-Earle; A W Williams; C M Steel; C C Bird
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

6.  Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q.

Authors:  E C Mariman; S E van Beersum; C W Cremers; F M van Baars; H H Ropers
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

7.  DNA methylation represses FMR-1 transcription in fragile X syndrome.

Authors:  J S Sutcliffe; D L Nelson; F Zhang; M Pieretti; C T Caskey; D Saxe; S T Warren
Journal:  Hum Mol Genet       Date:  1992-09       Impact factor: 6.150

8.  A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter.

Authors:  P Heutink; A G van der Mey; L A Sandkuijl; A P van Gils; A Bardoel; G J Breedveld; M van Vliet; G J van Ommen; C J Cornelisse; B A Oostra
Journal:  Hum Mol Genet       Date:  1992-04       Impact factor: 6.150

9.  Is there evidence for anticipation in autosomal-dominant polycystic kidney disease?

Authors:  G M Fick; A M Johnson; P A Gabow
Journal:  Kidney Int       Date:  1994-04       Impact factor: 10.612

10.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

View more
  16 in total

1.  Fine mapping of the split-hand/split-foot locus (SHFM3) at 10q24: evidence for anticipation and segregation distortion.

Authors:  R S Ozen; B E Baysal; B Devlin; J E Farr; M Gorry; G D Ehrlich; C W Richard
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

2.  Familial paraganglioma.

Authors:  A Cemal Umit Işik; Cihangir Erem; Mehmet Imamoğlu; Akif Cinel; Ahmet Sari; Gülden Maral
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-30       Impact factor: 2.503

3.  Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty.

Authors:  Margarita Raygada; Kathryn S King; Karen T Adams; Constantine A Stratakis; Karel Pacak
Journal:  J Pediatr Endocrinol Metab       Date:  2014-09       Impact factor: 1.634

4.  Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Authors:  E K Goldberg; J M Glendening; Z Karanjawala; A Sridhar; G J Walker; N K Hayward; A J Rice; D Kurera; Y Tebha; J W Fountain
Journal:  Am J Hum Genet       Date:  2000-07-29       Impact factor: 11.025

5.  Cervical paragangliomas: neurovascular surgical risk and therapeutic management.

Authors:  J Paris; F Facon; J M Thomassin; M Zanaret
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-06       Impact factor: 2.503

Review 6.  SDHC mutations in hereditary paraganglioma/pheochromocytoma.

Authors:  Ulrich Müller; Christian Troidl; Stephan Niemann
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 7.  Hereditary paragangliomas.

Authors:  Margarita Raygada; Barbara Pasini; Constantine A Stratakis
Journal:  Adv Otorhinolaryngol       Date:  2011-02-24

8.  Cervical paragangliomas: is SDH genetic analysis systematically required?

Authors:  Nicolas Fakhry; Patricia Niccoli-Sire; Anne Barlier-Seti; Roch Giorgi; Antoine Giovanni; Michel Zanaret
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-07       Impact factor: 2.503

Review 9.  Hereditary paraganglioma targets diverse paraganglia.

Authors:  B E Baysal
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

10.  Founder effect at PGL1 in hereditary head and neck paraganglioma families from the Netherlands.

Authors:  E M van Schothorst; J C Jansen; E Grooters; D E Prins; J J Wiersinga; A G van der Mey; G J van Ommen; P Devilee; C J Cornelisse
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.